e-learning
resources
Vienna 2012
Monday, 03.09.2012
Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effectiveness of MDR TB treatment in children and adolescents depending on its duration
G. Bekembaeva, A. Alenova, L. Kastykpaeva (Almaty, Kazakhstan)
Source:
Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Session:
Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Session type:
Thematic Poster Session
Number:
2688
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Bekembaeva, A. Alenova, L. Kastykpaeva (Almaty, Kazakhstan). The effectiveness of MDR TB treatment in children and adolescents depending on its duration. Eur Respir J 2012; 40: Suppl. 56, 2688
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Effectiveness of treatment for MDR TB in children and adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains
Source: Eur Respir J 2006; 28: Suppl. 50, 536s
Year: 2006
The comparative analysis of treatment effectiveness in children and adolescents with MDR TB with anti-TB drugs of the first and second lines
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
The clinical features and treatment of cases with MDR TB of adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Using results of drug sensitivity of infection source in initial chemotherapy choice in TB children and teenagers
Source: Eur Respir J 2006; 28: Suppl. 50, 12s
Year: 2006
Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
The causes of ineffectiveness of treatment of tuberculosis in children
Source: Eur Respir J 2005; 26: Suppl. 49, 649s
Year: 2005
Identification and clinical management of LTBI in children versus adults
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014
The effectiveness of the treatment of patients with TB in the condition adapted DOTS-strategy in Ukraine
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008
The effectiveness and safety of empirical anti-TB therapy in a population with high TB prevalence
Source: Eur Respir J 2001; 18: Suppl. 33, 468s
Year: 2001
Efficacy of treatment in MDR and XDR lung TB patients in the follow-up period with the use of new anti-tuberculosis agent
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Comparison of compliance of two therapeutic regimens in treatment of latent tuberculosis infection in Belgrade children
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004
Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
TB-incidence and role of preventive chemotherapy in children and adolescents from bacillary DR TB-pestholes
Source: Eur Respir J 2007; 30: Suppl. 51, 413s
Year: 2007
Eligibility for WHO shorter MDR treatment regimen among foreign-born MDR PTB patients in Singapore
Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Year: 2017
The depressive syndrome as a response to the TB treatment in MDR TB patients
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update
Source: Eur Respir J, 57 (5) 2002483; 10.1183/13993003.02483-2020
Year: 2021
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program
Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept